Saturday, 20 September 2014
|NZX : PEB|
19 Sep 14 00:00
Pacific Edge is a New Zealand based biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer.
Two products have recently completed successful clinical trials, bladder cancer detection and colorectal cancer prognosis (CRC). The bladder cancer technology Cxbladder® has been released to the market in Australia and New Zealand. CRC is being readied for commercial release. Pipeline products still in development include gastric and endometrial cancers and melanoma.
Cxbladder® is a non-invasive, accurate test that enables the early detection of bladder cancer from a small volume of urine providing general practitioners and urologists with a quick, cost effective and accurate measure of the presence of the cancer and provides urologists with the opportunity to reduce their reliance on the need for invasive tests such as cystoscopy.
The Company is commercialising its products from its new diagnostic laboratory in New Zealand and plans further commercialisation in the US and Europe as a centralised diagnostic service through its own facilities or as a turn-key solution, licensed to selected partners. Pacific Edge has plans for further studies in key markets to engage leading medical and urological opinion leaders who will be vital to success in new markets.
|Issuer:||Pacific Edge Limited|
|Solicitor:||Anderson Lloyd Caudwell Dunedin|
|Registry:||LINK MARKET SERVICES LIMITED|
|Auditor:||Pricewaterhouse Coopers Dunedin|
|Settlement:||NZCDC Settlement System|
|52 wk High:||1.7600|
|52 wk Low:||0.4900|
Pacific Edge Limited
87 St David Street
00:22 | 20/9/14
Mr. Erickson said Tesla has developed a distinct edge over other mainstream automakers that manufacture electric vehicles (EV), and it does not face the same challenges relating to a sluggish EV market that these automakers face. more»
07:52 | 19/9/14
As Founding Partners they will join other industry leading decision makers and a hand-picked selection of top level buyers from across Asia, at this cutting edge conference. The Bett Asia Leadership Summit will bring together senior government ... more»
We've all seen this evolution of technology and the resulting increased demand play out again and again, and from our position in the Pacific Northwest, we can see and experience this cycle from the front row. But even ... Of course, I'm referring to ... more»
“For the past several decades, Ronnie and Barbara Chan have been stellar ambassadors for USC, particularly in the Pacific Rim, and their most recent gift reflects their long-standing commitment to the university,” said USC President C. L. Max Nikias ... more»
04:30 | 18/9/14
The Asia-Pacific market for pea protein is projected to grow at the highest CAGR of more than 9% during the review period, due to the increasing demand of pea proteins for food applications in emerging markets such as China, India, and Japan. more»
NOTICE OF CHANGE IN ISSUED CAPITAL STOCK - ORDINARY SHARES
Pursuant to Listing Rule 7.3.5
Company: Pacific Edge Limited ISIN NZPEBE0002S1
Date: 5 July 2013
Date of Is more»
NOTICE OF APPOINTMENT OF INDEPENDENT DIRECTOR
Pursuant to Listing Rule 3.3
Date: 4 July 2013
Company: Pacific Edge Limited
Pacific Edge Limited is pleased to announce that more»
Please find attached the 2013 Annual Report.
End CA:00237882 For:PEB Type:ANNREP Time:2013-06-27 10:47:29 more»
See attached presentation
End CA:00237343 For:PEB Type:ADDRESS Time:2013-06-13 09:52:00 more»
PRELIMINARY FULL YEAR DISCLOSURE
Pacific Edge Limited
Year End 31 March 2013
FY2013 Results Summary
- Sales and marketing of Cxbladder launched in the USA - the world''s larg more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW